Literature DB >> 23636608

The influence of high glucose on the Cip/Kip family expression profiles in HRECs.

Jingyi Tian1, Hongjie Ma, Yan Luo, Andina Hu, Shaofen Lin, Tao Li, Kai Guo, Jing Li, Meng Cai, Shibo Tang.   

Abstract

Neovascularization is the main characteristic of the proliferative stage of diabetic retinopathy. It has been proven that cell cycle regulation is involved in angiogenesis. The cell cycle regulators, Cip/Kip protein family, belong to the cyclin-dependent kinase inhibitors, are versatile proteins, and except for their function in cell cycle regulation, they also participate in transcription, apoptosis and migration. The expression profiles of the Cip/Kip family in human retina microvascular endothelial cells (HRECs) under normal or high glucose conditions has not been described before. This study was undertaken to determine the expression profiles of the Cip/Kip family proteins, e.g., proteins which are influenced by high glucose and in what manner. Western blot and immunofluorescence analyses were used to investigate the protein expression profiles. Only p21(cip1) and p27(kip1) were detected in HRECs, and they were located in the nucleus. P21(cip1) protein abundance was higher than p27(kip1) in HRECs. Incubation of HRECs in medium containing 30 mM D-glucose for 48 h resulted in downregulation of p21(cip1) protein expression, but had no influence on p27(kip1) protein levels or p21(cip1) mRNA abundance. These results were accompanied by cell cycle G1 phase exit and a lower cell survival rate. Our data show for the first time that high glucose changes the Cip/Kip family expression profiles in HRECs, which may be the foundation for the investigation of the role of the Cip/Kip family in the pathogenesis of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23636608     DOI: 10.1007/s10735-013-9510-y

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  37 in total

Review 1.  CDK inhibitors: cell cycle regulators and beyond.

Authors:  Arnaud Besson; Steven F Dowdy; James M Roberts
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

2.  High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases.

Authors:  G Wolf; R Schroeder; G Zahner; R A Stahl; S J Shankland
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Role of nitric oxide in high glucose-induced mitogenic response in renal fibroblasts.

Authors:  Lea-Yea Chuang; Jinn-Yuh Guh; Ke-Ann Wang; Yann-Jia Huang; Jau-Shyang Huang
Journal:  Mol Endocrinol       Date:  2006-06-08

Review 4.  Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Cell Cycle       Date:  2010-06-15       Impact factor: 4.534

5.  Sprouty1 inhibits angiogenesis in association with up-regulation of p21 and p27.

Authors:  Sangjin Lee; Tri M Bui Nguyen; Dmitry Kovalenko; Neeta Adhikari; Suzanne Grindle; Sean P Polster; Robert Friesel; Sundaram Ramakrishnan; Jennifer L Hall
Journal:  Mol Cell Biochem       Date:  2010-01-07       Impact factor: 3.396

6.  Erk 1,2 phosphorylates p27(Kip1): Functional evidence for a role in high glucose-induced hypertrophy of mesangial cells.

Authors:  G Wolf; R Reinking; G Zahner; R A K Stahl; S J Shankland
Journal:  Diabetologia       Date:  2003-07-10       Impact factor: 10.122

7.  The structural plasticity of the C terminus of p21Cip1 is a determinant for target protein recognition.

Authors:  Vicent Esteve; Núria Canela; Aina Rodriguez-Vilarrupla; Rosa Aligué; Neus Agell; Ismael Mingarro; Oriol Bachs; Enrique Pérez-Payá
Journal:  Chembiochem       Date:  2003-09-05       Impact factor: 3.164

8.  Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle.

Authors:  Mai Yamauchi; Shinobu Imajoh-Ohmi; Masabumi Shibuya
Journal:  Cancer Sci       Date:  2007-07-26       Impact factor: 6.716

9.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

Authors:  M H Lee; I Reynisdóttir; J Massagué
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

Review 10.  The intricacies of p21 phosphorylation: protein/protein interactions, subcellular localization and stability.

Authors:  Emma S Child; David J Mann
Journal:  Cell Cycle       Date:  2006-06-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.